Wednesday, May 18

Modernity has risen 700 percent in value through the pandemic

The biotechnology company Moderna has multiplied its value since the first eruptions in Wuhan. But now at the end of the pandemic, the stock price may need a new booster.

The market value of the biotechnology company Moderna has risen by approx. 700 percent through the pandemic.

Already a subscriber to Aftenposten? Check if you have access to everything from E24

Leave a Reply

Your email address will not be published.